跳至主要内容
临床试验/NL-OMON46129
NL-OMON46129已完成不适用

An open-label, low interventional clinical study investigating error rates (critical and overall) prior to any retraining in correct use of the ELLIPTA dry powder inhaler (DPI) compared to other DPIs including; DISKUS, Turbuhaler, HandiHaler and Breezhaler as a monotherapy or in combination, in adult patients with Chronic Obstructive Pulmonary Disease (COPD) (study 204981) - 204981

GlaxoSmithKline0 个研究点目标入组 360 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
360

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • * *40 years of age.
  • * Currently receiving maintenance therapy with one of the treatments listed in table 1 of the protocol (page 17-18).

排除标准

  • * Participants who have been trained during participation in any device study in the 6 months prior to entry into this study
  • * Drug/alcohol abuse.

研究者

相似试验